Institutional Holder BAF Reports 3.46M BIOX Shares (5.52%)

Rhea-AI Filing Summary

BAF Latam Credit Fund B.V. reports beneficial ownership of 3,461,430 ordinary shares of Bioceres Crop Solutions Corp. (BIOX), representing 5.52% of the class based on the issuer's reported outstanding share count of 62,712,602. The filing states BAF holds sole voting power and sole dispositive power over the disclosed shares.

The statement was submitted on Schedule 13G and includes an Item 10 certification that the securities were not acquired to change or influence control of the issuer, indicating the filer describes the position as passive under the Schedule 13G framework.

Positive

• BAF disclosed beneficial ownership of 3,461,430 shares, representing 5.52% of BIOX's outstanding class.
• Sole voting and sole dispositive power over the disclosed shares is explicitly reported.
• Filed on Schedule 13G with Item 10 certification stating the position was not acquired to change control, clarifying passive intent.

Negative

• None.

Insights

Financial Analyst

TL;DR: BAF reports a passive, >5% stake in BIOX with full voting and dispositive powers over 3.46M shares.

From a capital markets perspective this Schedule 13G discloses a material minority holding: 3,461,430 shares (5.52%). The filing explicitly records sole voting and dispositive authority for those shares, which means BAF can exercise voting rights on that block but has certified the position as passive under Schedule 13G. The disclosure improves transparency around shareholder composition but does not, by itself, signal an intent to change control.

Corporate Governance Expert

TL;DR: Ownership crosses the 5% reporting threshold and is documented as passive with a formal certification against control-seeking.

The filing identifies BAF Latam Credit Fund B.V. as a non-U.S. entity organized in the Netherlands holding sole voting and dispositive power over the disclosed shares. The use of Schedule 13G and the Item 10 certification are procedurally consistent with a passive investor disclosure. This provides clarity for governance registers about a concentrated, but non-controlling, shareholder position.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Bioceres Crop Solutions Corp.

(Name of Issuer)

Ordinary Shares, $0.0001 par value

(Title of Class of Securities)

G1117K114

(CUSIP Number)

07/03/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G1117K114

1

Names of Reporting Persons

BAF Latam Credit Fund B.V.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NETHERLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,461,430.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,461,430.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,461,430.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.52 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Calculation based upon 62,712,602 ordinary shares issued and outstanding, as reported in Form 6-K filed by the Issuer on June 20, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Bioceres Crop Solutions Corp.
(b)	Address of issuer's principal executive offices: Ocampo 210 bis Predio CCT Rosario Santa Fe, Argentina 2000.
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of BAF Latam Credit Fund B.V. ("BAF").
(b)	Address or principal business office or, if none, residence: De Boelelaan 7, 1083HJ, Amsterdam, The Netherlands.
(c)	Citizenship: BAF is a private limited company organized under the laws of The Netherlands.
(d)	Title of class of securities: Ordinary Shares, $0.0001 par value
(e)	CUSIP No.: G1117K114
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,461,430
(b)	Percent of class: 5.52%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3,461,430.00
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3,461,430.00
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BAF Latam Credit Fund B.V.

Signature:	/s/ Robert H. Louzada
Name/Title:	Robert H. Louzada/Director
Date:	08/13/2025

FAQ

How many BIOX shares does BAF Latam Credit Fund B.V. own?

3,461,430 ordinary shares as reported in the Schedule 13G.

What percentage of BIOX does that holding represent?

5.52% of the class, based on the issuer's reported outstanding share count of 62,712,602.

Does BAF have voting or dispositive power over these shares?

Yes. The filing states BAF has sole voting power and sole dispositive power over the disclosed shares.

Was the stake reported as passive or active?

Passive. The Schedule 13G filing includes an Item 10 certification that the securities were not acquired to change or influence control.

Where is BAF Latam Credit Fund B.V. organized?

The Netherlands; the filing lists the principal business address as De Boelelaan 7, 1083HJ, Amsterdam.

Who signed the filing on behalf of BAF?

Robert H. Louzada, Director, signed the Schedule 13G for BAF Latam Credit Fund B.V.